Aptabio Therapeutics, Inc.

This is the first human study testing a new oral medication called ABF-101 for age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The study will check if the drug is safe and how it moves through the body in 68 healthy volunteers and people wi…

This is the first human study of a new experimental drug called APX-343A for people with advanced solid tumors that have spread. The main goal is to find a safe dose and see how the body handles the drug, both by itself and when combined with an existing immunotherapy (pembrolizu…

This study is testing whether a new oral medication called APX-115 can prevent kidney damage caused by the dye used during common heart procedures. It will involve about 280 adults with reduced kidney function who are scheduled for a coronary angioplasty. Participants will be ran…